In addition, some untreated patients with PBC had detectable ESR1 mutations in their plasma, which were not consistent with what it is known from the literature: ESR1 LBD mutations are extremely rare in the early setting and can be identified in a significant proportion of MBC patients that have been exposed to AIs. This evidence concerns the gene ESR1 and primary biliary cholangitis.